Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer
Clinical trial NCT05232175 · COMPLETED
Trial details
- NCT number
- NCT05232175
- Sponsor
- Alteogen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-18
- Primary completion
- 2022-08-24
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.